[Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs].
Suzuki
Katsuji
K
Department of Psychiatry, Hokkaido University Graduate School of Medicine.
Koyama
Tsukasa
T
D018759:Adrenergic Uptake Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology; D000928:Antidepressive Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D018692:Antimanic Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002220:Carbamazepine / Q000493:pharmacokinetics / Q000494:pharmacology; D003521:Cyclopropanes / Q000493:pharmacokinetics / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000502:physiology; D004347:Drug Interactions; D016666:Fluvoxamine / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007527:Isoenzymes / Q000502:physiology; D008094:Lithium / Q000493:pharmacokinetics / Q000494:pharmacology; D000078764:Milnacipran; D017374:Paroxetine / Q000493:pharmacokinetics / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology; D014635:Valproic Acid / Q000493:pharmacokinetics / Q000494:pharmacology
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D018692:Antimanic Agents; D002220:Carbamazepine; D003521:Cyclopropanes; D003577:Cytochrome P-450 Enzyme System; D016666:Fluvoxamine; D007527:Isoenzymes; D008094:Lithium; D000078764:Milnacipran; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014635:Valproic Acid